Annual Drug Patent Expirations for XIIDRA Xiidra is a drug marketed by Shire Dev Llc and is included in one NDA. It is available from one supplier. There are fourteen…
Posts published in “Patent Added”
Annual Drug Patent Expirations for ENSTILAR Enstilar is a drug marketed by Leo Pharma As and is included in one NDA. It is available from one supplier. There are two…
Annual Drug Patent Expirations for UCERIS Uceris is a drug marketed by Valeant Pharms Intl and is included in two NDAs. It is available from three suppliers. There are twelve…
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Avanir Pharms and is included in one NDA. It is available from one supplier. There are fifteen…
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. The generic ingredient in NUZYRA is omadacycline tosylate. Additional…
Annual Drug Patent Expirations for EPANOVA Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are eight patents protecting this drug. This drug has…
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are eleven…
Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme and Schering and is included in three NDAs. It is available from one supplier. There…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-five…
Annual Drug Patent Expirations for ZERBAXA Zerbaxa is a drug marketed by Cubist Pharms Llc and is included in one NDA. It is available from one supplier. There are seven…